Next quarter the $6.60 will become $5.50, then $4.75, then $3.75 until the chapter 11 restructuring is announced due to debt loads
They need to start selling assets immediately or issue a secondary share offering or bankruptcy will be imminent
Valeant will be sharing SIX abstracts on products in development with them. And you people think that this stock isn't going higher? And shorty, if it such a black sheep of the pharma industry, how come they got invited to ASCO in the first place?
see you at $31 by close.
-Papa/Pearson 1-2 punch
-Ackman on the board
-Senate Committee gone
-10-K filed on time and nothing material adverse contained within it
-10-Q coming this week
-Companies are starting to competitively bid for VRX assets
Things are ONLY going to get BETTER for shareholders from here. Ackman would have walked away if it were not the case. Sit tight and enjoy the ride higher folks.
If the smartest people in pharma were willing to acquire the company at north of $60, what does that tell you about the true worth of the company?
Anyone who knows about American Society of Clinical Oncology (ASCO) taking place this week, knows it is the biggest pharma meeting of the year - Valeant will be giving SIX presentations. Institutional fund managers will be in attendance. The story keeps getting better and better here, folks.
With Pearson behind the scenes, Papa will have someone to lean on to help sort out the mess. And lets be honest, say what you will about Mikey Pearson, but he does know how to focus really well on the bottom dollar.